Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | less than 1 min read | 04.21.26
Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.
Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates.
The financing transaction was led by partner Kurt Machemer (Boston).
Read more here.
Insights
Firm News | 2 min read | 10.23.26
Three Crowell Lawyers Named to IAM Global Leaders 2027
Washington – October 23, 2026: Crowell & Moring’s Kristof Roox, Jan-Diederik Lindemans, and Justin Hill have been named to IAM Global Leaders 2027, which recognizes leading patent practitioners worldwide.
Firm News | 2 min read | 10.22.26
Crowell & Moring Adds Veteran DOJ Health Care Litigator Jeff McSorley
Firm News | 1 min read | 10.21.26
Crowell & Moring Named Litigation Team of the Year at Law.com Middle East Legal Awards
Firm News | 2 min read | 10.20.26
